Characteristics | No diabetes | P | Type 2 diabetes | P | ||||
---|---|---|---|---|---|---|---|---|
 | Total | No MetS | MetS |  | Total | No MetS | MetS |  |
 | (n = 2,308) | (n = 1,515) | (n = 793) |  | (n = 561) | (n = 176) | (n = 385) |  |
Subjects | Â | Â | Â | Â | Â | Â | Â | Â |
Age (years) | 57 ± 9 | 57 ± 9 | 57 ± 9 | 0.526 | 60 ± 9* | 61 ± 9 | 60 ± 8 | 0.219 |
Men, n (%) | 1,155 (50) | 749 (49) | 406 (51) | 0.430 | 313 (56)†| 105 (60) | 208 (54) | 0.234 |
Body mass index (kg/m2) | 24.4 ± 2.8 | 23.6 ± 2.6 | 25.9 ± 2.5 | <0.001 | 25.0 ± 3.0* | 23.1 ± 2.3 | 25.9 ± 3.0 | <0.001 |
Current smoking, n (%) | 277 (12) | 176 (12) | 101 (13) | 0.500 | 76 (14) | 23 (14) | 53 (14) | 0.876 |
SBP (mmHg) | 126 ± 15 | 124 ± 14 | 130 ± 15 | <0.001 | 128 ± 15†| 123 ± 13 | 130 ± 16 | <0.001 |
DBP (mmHg) | 79 ± 10 | 78 ± 9 | 81 ± 10 | <0.001 | 78 ± 10 | 76 ± 9 | 79 ± 10 | <0.001 |
Antihypertensive treatment, n (%) | 1,098 (49) | 628 (43) | 470 (61) | <0.001 | 298 (54)†| 61 (36) | 237 (63) | <0.001 |
Total cholesterol (mg/dL) | 188 ± 35 | 187 ± 34 | 190 ± 37 | 0.047 | 181 ± 37* | 176 ± 36 | 183 ± 38 | 0.045 |
Triglyceride (mg/dL) | 140 ± 91 | 115 ± 61 | 190 ± 114 | <0.001 | 160 ± 102* | 105 ± 50 | 185 ± 109 | <0.001 |
HDL cholesterol (mg/dL) | 51 ± 12 | 54 ± 12 | 45 ± 10 | <0.001 | 48 ± 11* | 54 ± 11 | 46 ± 10 | <0.001 |
LDL cholesterol (mg/dL) | 120 ± 33 | 120 ± 32 | 120 ± 34 | 0.850 | 114 ± 38* | 115 ± 42 | 114 ± 36 | 0.670 |
Creatinine (mg/dL) | 0.90 ± 0.16 | 0.90 ± 0.16 | 0.91 ± 0.16 | 0.182 | 0.91 ± 0.16 | 0.91 ± 0.17 | 0.90 ± 0.16 | 0.779 |
GFR (mL/min/1.73 m2) | 82 ± 13 | 82 ± 13 | 82 ± 13 | 0.235 | 83 ± 14 | 83 ± 14 | 82 ± 14 | 0.513 |
FBS (mg/dL) | 95 ± 10 | 93 ± 9 | 100 ± 11 | <0.001 | 135 ± 43* | 133 ± 42 | 135 ± 44 | 0.584 |
Duration of diabetes (years) | - | - | - | - | 11 ± 7 | 12 ± 7 | 10 ± 7 | 0.094 |
Anti-diabetic treatment, n (%) | - | - | - | - | 433 (77) | 133 (76) | 300 (78) | 0.588 |
Coronary atherosclerosis parameters, n (%) | Â | Â | Â | Â | Â | Â | Â | Â |
Any plaque | 981 (43) | 597 (26) | 384 (48) | <0.001 | 359 (64)* | 104 (59) | 255 (66) | 0.108 |
CMP | 797 (35) | 480 (32) | 317 (40) | <0.001 | 311 (55)* | 96 (55) | 215 (56) | 0.784 |
NCP | 184 (8) | 117 (8) | 67 (8) | 0.571 | 48 (9) | 8 (5) | 40 (10) | 0.022 |
Obstructive plaque | 292 (13) | 171 (11) | 121 (15) | 0.007 | 145 (26)* | 44 (25) | 101 (26) | 0.835 |
Obstructive CMP | 244 (11) | 140 (9) | 104 (13) | 0.005 | 122 (22)* | 39 (22) | 83 (22) | 0.912 |
Obstructive NCP | 48 (2) | 31 (2) | 17 (2) | 0.876 | 23 (4)†| 5 (3) | 18 (5) | 0.366 |
CACS ≥ 100 | 264 (12) | 155 (10) | 109 (14) | 0.013 | 129 (23)* | 41 (23) | 88 (23) | 0.946 |